Österreich » News & Media » Pressemitteilungen

Details

04.04.12

STALLERGENES HAS IDENTIFIED TWO CANDIDATE BIOMARKERS

 

Antony (France), 2 April 2012 – Stallergenes SA (Euronext Paris CAC small) today announced the publication1 in the April issue of Journal of Allergy and Clinical Immunology (JACI) of an article presenting the identification of two candidates as biomarkers of early efficacy of allergen immunotherapy (AIT) as the hallmark of a regulatory innate immune response predictive of clinical tolerance